This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Thrombospondin
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> describing Jmol <ref>PMID:21638687</ref> to the rescue. == Function == Thrombospondi...) |
|||
| (12 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | <StructureSection load='' size='350' side='right' caption='Human TSP-1 Nterminal complex with Arixtra heparin (PDB code [[1za4]])' scene='74/748873/Cv/3'> | ||
| - | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| - | describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
== Function == | == Function == | ||
| Line 8: | Line 7: | ||
== Relevance == | == Relevance == | ||
TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>. | TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>. | ||
| - | == Structural highlights == | ||
| + | == Disease == | ||
| + | TSP-2 mutation is associated with coronary artery disease<ref>PMID:18499674</ref>. | ||
| + | |||
| + | == Structural highlights == | ||
| + | The N-terminal of TSP-1 mediates its interaction with integrins during cell adhesion, with lipoproteinreceptor-related protein during uptake and clearance and with fibrinogen during platelet aggregation. The <scene name='74/748873/Cv/4'>arginine and lysine side chains of the N-terminal interact with the heparin sulfate groups</scene><ref>PMID:16407063</ref>. | ||
</StructureSection> | </StructureSection> | ||
| Line 15: | Line 18: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| + | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| + | |||
| + | *Thrombospondin-1 | ||
| + | |||
| + | **[[1ux6]] – hTSP-1 C-terminal (mutant) 831-1170 + Ca - human<br /> | ||
| + | **[[1lsl]], [[3r6b]] – hTSP-1 repeats 2-3 434-547<br /> | ||
| + | **[[1z78]], [[2erf]], [[2es3]], [[2ouh]], [[2ouj]] – hTSP-1 N-terminal 25-233<br /> | ||
| + | **[[7yyk]] – hTSP-1 378-547<br /> | ||
| + | **[[1za4]] – hTSP-1 N-terminal + heparin<br /> | ||
| + | |||
| + | *Thrombospondin-2 | ||
| + | |||
| + | **[[1yo8]] – hTSP-2 C-terminal<br /> | ||
| + | **[[2rhp]] – hTSP-2 signature domain (mutant)<br /> | ||
| + | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
| + | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
3D structures of thrombospondin
Updated on 24-December-2023
References
- ↑ Adams JC. Thrombospondin-1. Int J Biochem Cell Biol. 1997 Jun;29(6):861-5. PMID:9304800
- ↑ Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med. 2012 May;2(5):a006627. doi:, 10.1101/cshperspect.a006627. PMID:22553494 doi:http://dx.doi.org/10.1101/cshperspect.a006627
- ↑ Carlson CB, Liu Y, Keck JL, Mosher DF. Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability. J Biol Chem. 2008 Jul 18;283(29):20069-76. Epub 2008 May 22. PMID:18499674 doi:10.1074/jbc.M800223200
- ↑ Tan K, Duquette M, Liu JH, Zhang R, Joachimiak A, Wang JH, Lawler J. The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin. Structure. 2006 Jan;14(1):33-42. PMID:16407063 doi:10.1016/j.str.2005.09.017
